Eric Cantor named president and CEO of PhRMA
Former House Majority Leader Eric Cantor was selected to serve as the next president and CEO of the Pharmaceutical Research and Manufacturers of America (PhRMA). Cantor will assume the role effective November 9. He previously served as Vice Chairman and Managing Director at Moelis & Company after leaving Congress in 2014.
3
Divergence score
3 outlets covered it, splitting into 3 framing camps across 2 bias groups.
3 camps
2 bias groups
The spectrum · how 3 outlets placed this story
LeftCenterRight
Breitbart
Politico
Washington Times
Supportive of action
Neutral
Dismissive
Critical
Alarmist
International angle
Widest split · the two outlets furthest apart, and who published first
First to report
- Politicofirst
- Breitbart+3.0 h
- Washington Times+3.2 h
By each outlet's earliest publish time in this story. Feeds that index slowly can appear later than they printed.
The split, in one line
Breitbart leads with the official announcement and Cantor's bipartisan credentials; Politico frames him as pharma's new top lobbyist; Washington Times calls it a consequential lobbying job.
How each outlet covered it
Lightly covered so far
Too few outlets to map a left-right split. Here is each take as it stands.
Sparse coverage · 3 outlets
“Pharma's new top lobbyist is former Majority Leader Eric Cantor - Politico”
“Eric Cantor Announced to Serve as President, CEO of PhRMA Organization”
“Former House majority leader named CEO of major pharma lobbying group”
4 tracked claims across 3 outlets
Fact ledger
All4Claimed2Corroborated2
1/3
Claimed
Cantor will assume the role effective November 9
Corroborated
Disputed
3 more tracked claimsSign up free to see the full ledger